Market Tracker

01/17 5:19pm ET

Nektar Therapeutics (NASDAQ:NKTR)

69.40
Delayed Data
As of 4:00pm ET
 -0.34 / -0.49%
Today’s Change
11.41
Today|||52-Week Range
75.33
+16.21%
Year-to-Date

Today’s Trading

Previous close69.74
Today’s open69.99
Day’s range68.52 - 70.98
Volume2,594,151
Average volume (3 months)2,142,675
Market cap$11.0B
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+31.82%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book121.25

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-0.14-0.13%
ONCESpark Therapeutics I...+0.21+0.41%
XONIntrexon Corp+0.48+3.49%
JUNOJuno Therapeutics In...+23.65+51.86%
Data as of 4:00pm ET, 01/17/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts